Adipose tissue-derived mesenchymal stem cells are safe and may improve sensation and movement after traumatic spinal cord injuries.

A groundbreaking human trial has begun that could transform life for people with spinal cord injuries. The project, developed ...

T.J. Atchinson, 21, is the first human with a spinal cord injury to undergo embryonic stem-cell therapy.

More information: Joel R. Martin et al, Long-term clinical and safety outcomes from a single-site phase 1 study of neural stem cell transplantation for chronic thoracic spinal cord injury, Cell ...

A research team has recently made a significant advancement in spinal cord injury treatment by using genetically modified human neural stem cells (hNSCs). They found that specifically modulating a ...

A research team from HKUMed has generated human neural stem cells with powerful therapeutic potential for the treatment of spinal cord injury that paves the way for new therapeutic opportunities ...

A Mayo Clinic study shows stem cells derived from patients' own fat are safe and may improve sensation and movement after traumatic spinal cord injuries.

XellSmart's stem cell therapy trial aims to cure spinal cord injuries, offering hope to millions affected worldwide.

The study found that all four patients tolerated the treatment well, and while the current study was only designed to assess safety and tolerability, the results suggest that neural stem cell ...

Geron Corp announces it has received FDA approval for a phase 1 safety trial of GRNOPC1, derived from human embryonic stem cells, in patients with acute spinal-cord injury.

Neural stem cell transplantation shows promise for treating chronic spinal cord injury Date: December 17, 2024 Source: University of California - San Diego Summary: Using neural stem cells could ...